,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, Anemia, Fatigue, Thrombocytopenia, Nausea, Pyrexia, Decreased Platelets, Dyspnea, Diarrhea, Decreased Lymphocyte, Headache, Cough, Edema Peripheral, Neutropenia, Decreased Phosphorus, Muscle Spasm, Upper Respiratory Tract Infection, Hypokalemia, Pneumonia, Constipation, Chills, Asthenia, Nasopharyngitis, Bronchitis, Rash, Embolic and Thrombotic Events, Venous, Febrile Neutropenia, Lymphopenia, Cardiac Arrest, Cardiac Failure, Myocardial Infarction, Myocardial Ischemia, Cataract, Vision Blurred, Abdominal Pain, Dyspepsia, Toothache, Pain, Influenza, Sepsis, Urinary Tract Infection, Viral Infection, Dehydration, Hyperkalemia, Hyperuricemia, Hypoalbuminemia, Hyponatremia, Muscular Weakness, Myalgia, Hypoesthesia, Paresthesia, Deafness, Anxiety, Delirium, Renal Failure, Renal Failure Acute, Renal Impairment, Dysphonia, Epistaxis, Oropharyngeal Pain, Pulmonary Embolism, Pulmonary Edema, Erythema, Hyperhidrosis, Pruritus, Deep Vein Thrombosis, Hypotension, Death."
1,KYPROLIS,warnings and precautions,"Cardiac toxicities, cardiac failure, myocardial infarction, death, myocardial ischemia, acute renal failure, renal insufficiency, renal impairment, renal failure, tumor lysis syndrome, TLS, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, PRES, embryo-fetal toxicity"
2,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, hypomagnesemia, QT prolongation, death, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, dyspeptic signs and symptoms, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis."
3,MULTAQ,boxed warnings,"Death, Stroke, Heart failure"
4,MULTAQ,warnings and precautions,"Cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, liver injury, acute liver failure, pulmonary toxicity, interstitial lung disease, pneumonitis, pulmonary fibrosis, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, death."
5,JUBLIA,adverse reactions,"Ingrown toenails, ingrown toenail, Application site dermatitis, Application site vesicles, Application site pain, death"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, death, constipation, vomiting, increased transaminases, hypokalemia, rash, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis."
7,TEFLARO,warnings and precautions,"Serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, direct Coombs' test seroconversion, drug-induced hemolytic anemia, death."
8,DATSCAN,adverse reactions,"Hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, Skin erythema, Pruritis, Anaphylactic reaction, Thyroid accumulation"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, death, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, elevated ALT, elevated AST, hyperglycemia, lipase, total neutrophils, elevated cholesterol, elevated HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, elevated creatine kinase, neutropenia, hepatitis B, hepatitis C, immune reconstitution syndrome, changes in serum creatinine."
11,TIVICAY,warnings and precautions,"Hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, death, Transaminase elevations, immune reconstitution syndrome, hepatitis B reactivation, hepatotoxicity, Fat redistribution, body fat accumulation, central obesity, dorsocervical fat enlargement, buffalo hump, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Immune reconstitution syndrome, inflammatory response, opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, Pyrexia, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, Pancreatitis, Hypersensitivity manifesting as bullous rash, Interstitial nephritis, Vision blurred, transient blindness, Stomatitis, Asthenia, Cellulitis, folliculitis, paronychia, rash pustular, Palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, Hypertension, death"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous malignancies, non-cutaneous malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, death"
14,HORIZANT,adverse reactions,"somnolence, sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts, behaviors, lack of interchangeability with gabapentin, drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, death"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, death, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, pneumonia, abdominal pain, atrial fibrillation, constipation, dyspnea, vomiting, decreased appetite, urinary tract infection, skin infections, sinusitis, peripheral edema, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, petechiae, laceration, anxiety, insomnia, hypertension, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, subdural hematoma, creatinine increase, vision blurred, contusion, anaphylactic shock, urticaria, angioedema."
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, infections, fatal infections, progressive multifocal leukoencephalopathy, cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"Liver function abnormalities, nausea, arthralgia, rash, death"
19,ULORIC,warnings and precautions,"Gout Flare, Cardiovascular Events, Myocardial Infarction, Stroke, Hepatic Effects, Hepatic Failure, Liver Injury, Transaminase Elevations, Fatigue, Anorexia, Right Upper Abdominal Discomfort, Dark Urine, Jaundice, Drug-induced Liver Injury, Death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, death, serious infections, malignancies, heart failure, Crohn's disease, rheumatoid arthritis, tuberculosis infections, pyrexia, urticaria, pneumonia, abdominal pain, diarrhea, intestinal obstruction, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, urticaria, thrombophlebitis, vasculitis, hypertension, headache, back pain, pharyngitis, acute bronchitis, fatigue, sarcoidosis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis."
21,CIMZIA,boxed warnings,"Serious infections, tuberculosis, invasive fungal infections, bacterial infections, viral infections, opportunistic infections, Legionella infections, Listeria infections, malignancy, lymphoma, death"
22,CIMZIA,warnings and precautions,"Serious infections, death, invasive fungal infections, lymphoma, heart failure, anaphylaxis, allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, central nervous system demyelinating disease, peripheral demyelinating disease, hematological reactions, pancytopenia, aplastic anemia, hypersensitivity reactions, hepatitis B virus reactivation, neurologic reactions, hematological reactions, autoimmunity, immunosuppression."
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, death"
24,KALYDECO,warnings and precautions,"Elevated transaminases, liver function abnormalities, Cataracts, Death"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count."
26,FULYZAQ,warnings and precautions,"Diarrhea, Death"
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, Application site erythema, Application site pain, Application site pruritus, Application site papules, Application site edema, Application site swelling, Application site dryness, Nasopharyngitis, Bronchitis, Sinusitis, Nausea, Vomiting, Pruritus, Hypertension, Application site urticaria, Application site paresthesia, Application site dermatitis, Application site hyperesthesia, Application site excoriation, Application site warmth, Application site anesthesia, Application site bruising, Application site inflammation, Application site exfoliation, Peripheral edema, Headache, Burning sensation, Peripheral sensory neuropathy, Dizziness, Dysgeusia, Hyperesthesia, Hypoesthesia, Cough, Throat irritation, Abnormal skin odor"
28,QUTENZA,warnings and precautions,"Eye irritation, Mucous membrane irritation, Coughing, Sneezing, Skin irritation, Transient increases in blood pressure, Pain, Increase in blood pressure, Death."
29,GRANIX,adverse reactions,"Splenic Rupture, death, Acute Respiratory Distress Syndrome, death, Serious Allergic Reactions, death, Use in Patients with Sickle Cell Disease, death, Capillary Leak Syndrome, death, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, death, Bone pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), Cutaneous vasculitis, Thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic rupture, death, Acute Respiratory Distress Syndrome (ARDS), death, Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, death, Capillary Leak Syndrome, death"
31,COARTEM,adverse reactions,"Headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, headache, death"
32,COARTEM,warnings and precautions,"Prolongation of the QT Interval, death, QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, electrolyte imbalance, long QT syndrome, sudden death, drug interactions, decreased efficacy, decreased exposure to lumefantrine, decreased concentrations of substrates, loss of substrate efficacy, increased concentrations of artemether and/or lumefantrine, potentiate QT prolongation, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased plasma concentrations of coadministered drugs, adverse effects, recrudescence, hepatic impairment, renal impairment, Plasmodium vivax infection."
33,APTIOM,adverse reactions,"Suicidal Behavior, Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, death"
34,APTIOM,warnings and precautions,"suicidal behavior, suicidal ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, death"
35,PROLIA,adverse reactions,"Hypocalcemia, death, serious infections, dermatologic adverse reactions, osteonecrosis of the Jaw, atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, decreases in serum calcium levels, serious infections, epidermal and dermal adverse events, ONJ, atypical femoral fractures, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, marked elevation in serum PTH, drug-related musculoskeletal pain."
36,PROLIA,warnings and precautions,"Hypersensitivity, anaphylactic reactions, death, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, musculoskeletal pain, bone, joint, muscle pain, suppression of bone turnover"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, death, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypokalemia, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, tremor, dizziness, insomnia, cough, dyspnea, rash, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, Neurological toxicities, death"
39,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), death, Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, death, Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, death, Tumor Lysis Syndrome, death, Neutropenia and Febrile Neutropenia, death, Elevated Liver Enzymes, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), total blood bilirubin, death, Leukoencephalopathy, Preparation and Administration Errors."
40,STENDRA,adverse reactions,"Headache, death, Flushing, Nasal congestion, Nasopharyngitis, Back pain, Upper respiratory infection (URI), Bronchitis, Influenza, Sinusitis, Sinus congestion, Hypertension, Dyspepsia, Nausea, Constipation, Rash, Dizziness, Arthralgia, Diarrhea, Edema peripheral, Fatigue, Angina, Unstable angina, Deep vein thrombosis, Palpitations, Gastritis, Gastroesophageal reflux disease, Hypoglycemia, Blood glucose increased, Alanine aminotransferase increased, Oropharyngeal pain, Stomach discomfort, Vomiting, Muscle spasms, Musculoskeletal pain, Myalgia, Pain in extremity, Depression, Insomnia, Somnolence, Vertigo, Cough, Dyspnea exertional, Epistaxis, Wheezing, Pruritus, Balanitis, Erection increased, Hematuria, Nephrolithiasis, Pollakiuria, Urinary tract infection, Electrocardiogram abnormal, Non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, prolonged erection, priapism, anatomical deformation of the penis, penile tissue damage, permanent loss of potency, sudden loss of vision in one or both eyes, non-arteritic anterior ischemic optic neuropathy (NAION), sudden decrease or loss of hearing, dizziness, lightheadedness, fainting, symptomatic hypotension, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, sexually transmitted diseases, death"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, death."
43,XIAFLEX,boxed warnings,"Corporal rupture, Penile fracture, Penile injury, Penile ecchymoses, Penile hematoma, Sudden penile detumescence, Penile ""popping"" sound or sensation"
44,XIAFLEX,warnings and precautions,"Tendon rupture, serious injury, ligament damage, skin laceration, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality, hypersensitivity reactions, anaphylaxis, pruritus, allergic reactions, corporal rupture (penile fracture), penile ecchymoses, hematoma, penile detumescence, penile ""popping"" sensation, severe penile hematoma, bleeding, ecchymosis, contusion, injection site hemorrhage."
45,XEOMIN,adverse reactions,"Hypersensitivity, Dysphagia, Breathing Difficulties, Spread of Effects from Toxin, Neck Pain, Muscle Weakness, Injection Site Pain, Musculoskeletal Pain, Eyelid Ptosis, Dry Eye, Dry Mouth, Diarrhea, Headache, Visual Impairment, Dyspnea, Nasopharyngitis, Respiratory Tract Infection, Eye Swelling, Nausea, Flu-like Symptoms, Allergic Dermatitis, Localized Allergic Reactions (swelling, edema, erythema, pruritus, rash), Herpes Zoster, Muscular Weakness, Muscle Spasm, Dysarthria, Myalgia, Hypersensitivity, Death."
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties, life-threatening symptoms, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, dysphagia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, corneal exposure, corneal ulceration, ectropion, ecchymosis"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous skin disorders, Exfoliative skin disorders, Interstitial lung disease, Hepatic toxicity, Keratitis, Rash, Dermatitis acneiform, Stomatitis, Paronychia, Dry skin, Decreased appetite, Nausea, Vomiting, Pruritus, Death, Dyspnea, Fatigue, Hypokalemia, Pulmonary toxicity, ILD-like adverse reactions, Sepsis, Pneumonia, Rash/acne, Aphthous stomatitis, Mucosal inflammation, Mouth ulceration, Oral mucosa erosion, Mucosal erosion, Mucosal ulceration, Nail infection, Nail bed infection, Cheilitis, Pruritus, Cystitis, Epistaxis, Rhinorrhea, Weight decreased, Pyrexia, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, death, Bullous skin disorders, exfoliative skin disorders, bullous lesions, blistering lesions, exfoliating lesions, cutaneous reactions, life-threatening cutaneous reactions, Interstitial lung disease, ILD, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, fatal event, death, Hepatic toxicity, hepatic impairment, liver test abnormalities, fatal hepatic impairment, Keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, Embryofetal toxicity, fetal harm."
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, hypertension, hypersensitivity, bilirubin elevations, AST, ALT, creatinine levels, death, febrile neutropenia, pneumonia, hypokalemia, dehydration, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, dry mouth, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, oral candidiasis, nasopharyngitis, weight decreased, anorexia, decreased appetite, hyperuricemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, skin reactions, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, SJS, TEN, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, death."
51,TREANDA,warnings and precautions,"Myelosuppression, death, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, SJS, TEN, fatal, other malignancies, extravsation, embryo-fetal toxicity."
52,CHOLINE,adverse reactions,"injection site reaction, death"
53,CHOLINE,warnings and precautions,"imaging errors, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging, allergic reactions, anaphylaxis, radiation exposure, increased risk for cancer"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, death, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, hemorrage, thrombosis, infarction, cerebral venous thrombosis, hepatobiliary disorders, pancreatic disorders, anti-drug antibodies"
55,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe pancreatitis, hemorrhagic pancreatitis, Glucose intolerance, Thrombosis, hemorrhage, Death"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, death, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide, GLP-1, hypersensitivity, systemic hypersensitivity, urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, PR interval prolongation, first degree AV block, amylase increase, lipase increase."
57,TRULICITY,boxed warnings,"Thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness, death"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death"
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, death"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, Imaging errors, Withdrawal signs and symptoms, Fatal reactions in premature or low birth-weight infants (death), Increased radiation exposure, Imaging errors due to conditions affecting the sympathetic nervous system, Thyroid accumulation, Hypertension"
61,DOTAREM,adverse reactions,"NSF, Hypersensitivity reactions, Acute kidney injury, Nausea, Headache, Injection site pain, Injection site coldness, Burning sensation, Feeling cold, Rash, Somnolence, Fatigue, Dizziness, Vomiting, Pruritus, Paresthesia, Dysgeusia, Pain in extremity, Anxiety, Hypertension, Palpitations, Oropharyngeal discomfort, Serum creatinine increased, Injection site reactions, Bradycardia, Tachycardia, Arrhythmia, Anaphylactoid reactions, Cardiac arrest, Respiratory arrest, Cyanosis, Pharyngeal edema, Laryngospasm, Bronchospasm, Angioedema, Conjunctivitis, Ocular hyperemia, Eyelid edema, Lacrimation increased, Hyperhidrosis, Urticaria, Coma, Convulsion, Syncope, Presyncope, Parosmia, Tremor, Muscle contracture, Muscle weakness, Diarrhea, Salivary hypersecretion, Malaise, Fever, NSF, Superficial phlebitis, Death"
62,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis, NSF, fatal event, death, fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic kidney disease, severe kidney disease, acute kidney injury, impaired elimination, gadolinium-based contrast agents, GBCAs, renal function, glomerular filtration rate, DOTAREM dose."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, other intracranial bleeding, fatal bleeding, non-intracranial fatal bleeding, any gastrointestinal bleeds, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"THROMBOTIC EVENTS, SPINAL/EPIDURAL HEMATOMA, DEATH"
66,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, blood loss, hemorrhage, thrombotic events, risk of bleeding, significant bleeding, fatal bleeding, risk of developing an epidural or spinal hematoma, thromboembolic events, major bleeding, neurological impairment, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions requiring intervention for hemodynamic compromise, excess of major bleeding, increased exposure to dabigatran, risk of stroke and systemic embolism, risk of recurrence of deep venous thrombosis and pulmonary embolism, death"
67,ELIQUIS,adverse reactions,"Thrombotic events, bleeding, spinal/epidural anesthesia or puncture, death, hypersensitivity reactions, drug hypersensitivity, skin rash, anaphylactic reactions, allergic edema, syncope, major bleeding, intracranial bleed, intracerebral bleeding, intraventricular bleeding, subdural bleeding, subarachnoid bleeding, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hematoma, menorrhagia, contusion, transaminases increased, alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma."
68,ELIQUIS,boxed warnings,"thrombotic events, spinal hematoma, epidural hematoma"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, stroke, blood loss, thrombotic events, bleeding, epidural hematoma, paralysis, neurological impairment, numbness, weakness, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, death, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis."
71,ZERBAXA,warnings and precautions,"Decreased efficacy, hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, death"
73,FERRIPROX,boxed warnings,"Agranulocytosis, Neutropenia, Serious infections, Death"
74,FERRIPROX,warnings and precautions,"Agranulocytosis, Neutropenia, death, Embryofetal Toxicity"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death"
76,DALVANCE,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, skin reactions, Infusion-related reactions, Hepatic effects, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Development of drug-resistant bacteria"
77,ARCAPTA,adverse reactions,"asthma-related death, death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
78,ARCAPTA,boxed warnings,"asthma-related death, death, asthma-related deaths, fatal event, LABA, long-acting beta 2-adrenergic agonists, salmeterol, indacaterol, ARCAPTA NEOHALER"
79,ARCAPTA,warnings and precautions,"asthma-related death, death, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, paradoxical bronchospasm, cardiovascular effects, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"Fatigue, Headache, Nausea, Diarrhea, Back pain, Pain in extremities, Upper abdominal pain, Arthralgia, Migraine, Flatulence, Oropharyngeal pain, Dizziness, Asthenia, Cough, Dyspepsia, Gastroesophageal reflux disease, Constipation, Palpitations, Rash, Death"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, Prolongation of PR interval, Prolongation of QTc interval, Prolongation of QRS interval"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis, Hypersensitivity reactions, death, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor."
83,GADAVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS, NSF, Fatal event: death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Diarrhea, Nausea, Elevated transaminases, Vomiting, Abdominal pain, Fatigue, Decreased appetite, Constipation, Convulsion, Pneumonia, Dyspnea, Dehydration, Pneumothorax, Gastric hemorrhage, General physical health deterioration, Pulmonary tuberculosis, Cardiac tamponade, Sepsis, Rash, Neuropathy, Vision disorder, Prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, Death."
86,ZYKADIA,warnings and precautions,"Severe or Persistent Gastrointestinal Toxicity, diarrhea, nausea, vomiting, abdominal pain, Hepatotoxicity, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, death, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, death, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, ILD, renal cyst, neuropathy, rash, syncope, weight increased, pain in extremity, muscle spasm, dizziness, headache, weight decreased, pneumonia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, ALT elevation, AST elevation, hypophosphatemia, neutropenia, lymphopenia, hypokalemia."
88,XALKORI,warnings and precautions,"Hepatotoxicity, liver testing, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, electrocardiograms, electrolytes, Bradycardia, heart rate, blood pressure, Severe Visual Loss, visual field defect, vision loss, Embryofetal Toxicity, fetal harm, death"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, swelling of tongue, swelling of throat, death"
90,BEPREVE,warnings and precautions,"Contamination, Irritation, Redness, Absorption, Death"
91,EDARBI,adverse reactions,"Diarrhea, death, Hypotension/orthostatic hypotension, Nausea, Asthenia, fatigue, Muscle spasm, Dizziness, dizziness postural, Cough, Rash, Pruritus, Angioedema"
92,EDARBI,boxed warnings,"Fetal toxicity, Injury to the developing fetus, Death"
93,EDARBI,warnings and precautions,"Fetal Toxicity, Hypotension, Renal Impairment, Oligohydramnios, Fetal lung hypoplasia, Skeletal deformations, Skull hypoplasia, Anuria, Hypotension, Renal failure, Death, Symptomatic hypotension, Impaired Renal Function, Oliguria, Progressive azotemia, Acute renal failure, Death."
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, death, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, dizziness, somnolence, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, confusional state, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, urinary retention, malaise, increased liver enzymes, weight gain, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
95,POTIGA,boxed warnings,"Retinal abnormalities, vision loss, abnormal visual acuity, retinal pigmentary abnormalities, vision changes, death"
96,POTIGA,warnings and precautions,"Urinary retention, skin discoloration, retinal abnormalities, vision loss, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behavior, death."
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, death"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, thrombotic/thromboembolic complications, oropharyngeal pain, increased AST, pharyngitis, back pain, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, hyperbilirubinemia, total bilirubin increased, ALT increased, AST increased, hyperbilirubinemia, thrombotic microangiopathy, acute renal failure, death."
100,PROMACTA,boxed warnings,Hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, liver enzyme elevations, hepatic decompensation, ascites, encephalopathy, indirect hyperbilirubinemia, abnormal serum liver tests, liver injury, thrombotic event, portal vein thrombosis, thrombotic/thromboembolic complications, venous events, arterial events, thromboembolism, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, cataracts"
102,INLYTA,adverse reactions,"Diarrhea, Hypertension, Fatigue, Decreased appetite, Nausea, Dysphonia, Palmar-plantar erythrodysesthesia syndrome, Weight decreased, Vomiting, Asthenia, Constipation, Hypothyroidism, Cough, Mucosal inflammation, Arthralgia, Stomatitis, Dyspnea, Abdominal pain, Headache, Pain in extremity, Rash, Proteinuria, Dysgeusia, Dry skin, Dyspepsia, Pruritus, Alopecia, Erythema, Dizziness, Upper abdominal pain, Myalgia, Dehydration, Epistaxis, Anemia, Hemorrhoids, Hematuria, Tinnitus, Lipase increased, Glossodynia, Pulmonary embolism, Rectal hemorrhage, Hemoptysis, Deep vein thrombosis, Retinal-vein occlusion/thrombosis, Polycythemia, Transient ischemic attack, Hemoglobin decreased, Lymphocytes (absolute) decreased, Platelets decreased, White blood cells decreased, Creatinine increased, Bicarbonate decreased, Hypocalcemia, ALP increased, Hyperglycemia, Lipase increased, Amylase increased, ALT increased, AST increased, Hypernatremia, Hypoalbuminemia, Hyperkalemia, Hypoglycemia, Hyponatremia, Hypophosphatemia, Hemoglobin increased, Hypercalcemia, Death"
103,INLYTA,warnings and precautions,"Hypertension, hypertensive crisis, arterial thrombotic events, death, venous thrombotic events, death, hemorrhagic events, death, cardiac failure, death, gastrointestinal perforation, death, fistula, hypothyroidism, thyroid dysfunction, reversible posterior leukoencephalopathy syndrome, proteinuria, liver enzyme elevation, hepatic impairment, pregnancy"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease exacerbation, Arrhythmias exacerbation, Congestive Heart Failure exacerbation, Headache, Dizziness, Nausea, Hypertension, Fatigue, Death"
105,NORTHERA,boxed warnings,"Supine hypertension, Elevated blood pressure while lying down"
106,NORTHERA,warnings and precautions,"Supine hypertension, cardiovascular events, hyperpyrexia, confusion, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, ischemic heart disease exacerbation, arrhythmias exacerbation, congestive heart failure exacerbation, allergic reactions, bronchial asthma, death"
107,JARDIANCE,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Urinary Tract Infections, Female Genital Mycotic Infections, Upper Respiratory Tract Infection, Increased Urination, Dyslipidemia, Arthralgia, Male Genital Mycotic Infections, Nausea, Volume Depletion, Increased Urination, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Phimosis, Urinary Tract Infections, Laboratory Tests, Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Increase in Hematocrit."
108,JARDIANCE,warnings and precautions,"Hypotension, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Urinary tract infections, Increased LDL-C, Death"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, death"
110,FANAPT,boxed warnings,"Death, Increased mortality, Risk of death, Cardiovascular events (e.g., heart failure, sudden death), Infectious events (e.g., pneumonia)"
111,FANAPT,warnings and precautions,"Death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight gain, Seizures, Orthostatic hypotension, dizziness, syncope, Leukopenia, neutropenia, agranulocytosis, Hyperprolactinemia, Body temperature regulation, Dysphagia, Suicide, Priapism, Cognitive and motor impairment."
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity Reactions, Renal Impairment, death, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, vomiting, gastroesophageal reflux disease, dyspepsia, Constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"Thyroid C-cell tumors, medullary thyroid carcinoma, death"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, death."
116,EYLEA,warnings and precautions,"Endophthalmitis, Retinal detachments, Increases in intraocular pressure, Arterial thromboembolic events, Nonfatal stroke, Nonfatal myocardial infarction, Vascular death, Death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, death, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Renal Failure, Ventricular Fibrillation, Cerebral Hemorrhage, Arrhythmia, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Mucosal Inflammation, Pain, Peripheral Edema, Hematuria, Dysuria, Dyspepsia, Hypotension, Gastritis, Intestinal Obstruction."
118,JEVTANA,boxed warnings,"Neutropenia, Death, Hypersensitivity, Generalized rash, Erythema, Hypotension, Bronchospasm"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, anemia, thrombocytopenia, pancytopenia, febrile neutropenia, neutropenic infections, sepsis, septic shock, infectious adverse events, neutropenic deaths, fatal infectious adverse events, grade 4 neutropenia, grade 3-4 neutropenia, Hypersensitivity reactions, severe hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, Gastrointestinal disorders, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, death, Renal failure, fatal outcomes, Elderly patients, fatal outcomes not related to disease progression, certain adverse reactions, neutropenia, febrile neutropenia, Hepatic impairment, Embryo-Fetal Toxicity, fetal harm."
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, death, hepatotoxicity, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
121,YERVOY,boxed warnings,"Enterocolitis, Hepatitis, Dermatitis (including toxic epidermal necrolysis), Neuropathy, Endocrinopathy, Death"
122,YERVOY,warnings and precautions,"Immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, intestinal perforation, death, immune-mediated hepatitis, hepatotoxicity, hepatic failure, hospitalization, death, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, death, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, death, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hospitalization, death, other immune-mediated adverse reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, myositis, polymyositis, ocular myositis, death."
123,FARXIGA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Female genital mycotic infections, vulvovaginal mycotic infection, vaginal infection, vulvovaginal candidiasis, vulvovaginitis, genital infection, genital candidiasis, fungal genital infection, vulvitis, genitourinary tract infection, vulval abscess, vaginitis bacterial, Nasopharyngitis, Urinary tract infections, urinary tract infection, cystitis, Escherichia urinary tract infection, genitourinary tract infection, pyelonephritis, trigonitis, urethritis, kidney infection, prostatitis, Back pain, Increased urination, pollakiuria, polyuria, urine output increased, Male genital mycotic infections, balanitis, fungal genital infection, balanitis candida, genital candidiasis, genital infection male, penile infection, balanoposthitis, balanoposthitis infective, genital infection, posthitis, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, dehydration, hypovolemia, orthostatic hypotension, Renal failure, blood creatinine increase, Bone fractures, Hypersensitivity reactions, angioedema, urticaria, hypersensitivity, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Increase in Low-Density Lipoprotein Cholesterol."
124,FARXIGA,warnings and precautions,"Hypotension, symptomatic hypotension, volume contraction, Impairment in renal function, renal function adverse reactions, serum creatinine increase, eGFR decrease, Hypoglycemia, low blood sugar, Genital mycotic infections, genital fungal infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C increase, Bladder Cancer, bladder neoplasms, Macrovascular outcomes, Death."
125,PICATO,adverse reactions,"local skin reactions, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, eyelid edema, eye pain, conjunctivitis"
126,PICATO,warnings and precautions,"Eye disorders, Severe eye pain, Chemical conjunctivitis, Corneal burn, Eyelid edema, Eyelid ptosis, Periorbital edema, Local skin reactions, Severe reactions (e.g., vesiculation/pustulation, erosion/ulceration), Hypersensitivity reactions, Anaphylaxis, Allergic contact dermatitis, Severe skin reactions in the treated area (erythema, crusting, swelling, vesiculation/postulation, erosion/ulceration), Death."
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, death, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, headache, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, abnormal dreams, urinary hesitation, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion, tachycardia, proteinuria, vital sign changes, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome."
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, risk of suicidal thinking, risk of suicidal behavior, worsening of suicidal thoughts, emergence of suicidal thoughts, death"
129,PRISTIQ,warnings and precautions,"suicidal thoughts, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, proteinuria, asthenia, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes (AST, ALT, gamma GT), rhabdomyolysis, osteomalacia, bone pain, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, polyuria, death."
131,STRIBILD,boxed warnings,"Lactic acidosis, Severe hepatomegaly with steatosis, Death, Acute exacerbation of hepatitis B"
132,STRIBILD,warnings and precautions,"Renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, bone mineral density decreases, osteomalacia, bone pain, fractures, muscular pain or weakness, redistribution/accumulation of body fat, immune reconstitution syndrome"
133,NULOJIX,adverse reactions,"PTLD, post-transplant lymphoproliferative disorder, CNS PTLD, non-CNS PTLD, malignancies, other malignancies, post-transplant lymphoproliferative disorder (PTLD), progressive multifocal leukoencephalopathy (PML), bacterial infections, mycobacterial infections, viral infections, fungal infections, cryptococcal meningitis, infusion reactions, proteinuria, new-onset diabetes after transplantation (NODAT), hypertension, dyslipidemia, anemia, leukopenia, graft dysfunction, peripheral edema, pyrexia, diarrhea, urinary tract infection, constipation, nausea, vomiting, headache, hypokalemia, hyperkalemia, death."
134,NULOJIX,boxed warnings,"Post-transplant lymphoproliferative disorder, PTLD, other malignancies, serious infections, increased risk for developing PTLD, increased risk for developing malignancies, increased susceptibility to infection, possible development of malignancies, increased risk of graft loss, death."
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), CNS involvement, Neurological signs and symptoms, Cognitive signs and symptoms, Behavioral signs and symptoms, Other malignancies, Increased risk of malignancies, Intensity and duration of immunosuppressant use, UV light exposure, Sunlight exposure, Progressive Multifocal Leukoencephalopathy (PML), Bacterial infections, Viral infections, Fungal infections, Protozoal infections, Opportunistic infections, Tuberculosis, Fatal infections, Polyoma virus-associated nephropathy, Kidney graft loss, Liver transplant use not recommended, Acute rejection, Graft loss, Corticosteroid minimization, Immunizations with live vaccines, death"
136,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, death"
137,LUMIZYME,boxed warnings,"Anaphylaxis, Hypersensitivity, Immune-mediated reactions, Cardiorespiratory failure, Respiratory distress, Hypoxia, Apnea, Dyspnea, Bradycardia, Tachycardia, Bronchospasm, Throat tightness, Hypotension, Angioedema (including tongue or lip swelling, periorbital edema, and face edema), Urticaria, Proteinuria, Nephrotic syndrome, Necrotizing skin lesions, Death"
138,LUMIZYME,warnings and precautions,"Anaphylaxis, Hypersensitivity Reactions, death, Immune-Mediated Reactions, Acute Cardiorespiratory Failure, Cardiac Arrhythmia, Sudden Cardiac Death, Antibody Development"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis, death, hypersensitivity reactions, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise."
140,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), Fibrosis affecting the skin, muscle, and internal organs, Fatal fibrosis, Debilitating fibrosis, Chronic, severe kidney disease, Acute kidney injury, Acute kidney injury and other conditions that may reduce renal function, Chronically reduced renal function, Age > 60 years, Hypertension, Diabetes, Death."
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Hypersensitivity, Anaphylactoid reactions, Cardiovascular reactions, Respiratory reactions, Cutaneous reactions, Shock, Acute Kidney Injury, Extravasation, Injection Site Reactions, Interference with Laboratory Tests, Interference with Visualization of Liver Lesions, death"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, tumor lysis syndrome, death, hepatic failure, ventricular fibrillation, febrile neutropenia."
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, death, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality."
144,VICTRELIS,adverse reactions,"Fatigue, Anemia, Nausea, Headache, Dysgeusia, Neutropenia, Pancytopenia, Hypersensitivity, Death (if fatal event is listed), Dry mouth, Diarrhea, Vomiting, Decreased appetite, Arthralgia, Dizziness, Insomnia, Irritability, Dyspnea exertional, Alopecia, Dry skin, Rash, Chills, Asthenia, Decreased hemoglobin, Decreased neutrophils, Decreased platelets, Agranulocytosis, Thrombocytopenia, Mouth ulceration, Stomatitis, Pneumonia, Sepsis, Angioedema, Urticaria, Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, Exfoliative rash, Exfoliative dermatitis, Stevens-Johnson syndrome, Toxic skin eruption, Toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, anemia, hemoglobin decrease, neutropenia, worsening neutropenia, hypersensitivity, acute hypersensitivity reactions, urticaria, angioedema, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, death"
147,VIMIZIM,boxed warnings,"Anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, respiratory compromise, hypersensitivity reactions, death"
148,VIMIZIM,warnings and precautions,"Anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, sleep apnea, airway patency, spinal cord compression, back pain, paralysis, urinary incontinence, fecal incontinence."
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, Nausea, Arthralgia, Headache, Hemoptysis, Chest Pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, Death"
150,SIRTURO,boxed warnings,"Increased Mortality, Death, QT Prolongation"
151,SIRTURO,warnings and precautions,"QT prolongation, Ventricular arrhythmia, Hepatotoxicity, Liver injury, Increased mortality (death), Torsade de Pointes, Congenital long QT syndrome, Hypothyroidism, Bradyarrhythmias, Heart failure, Hypocalcemia, Hypomagnesemia, Hypokalemia, Clinically significant ventricular arrhythmia (death), QTcF interval > 500 ms (death), Syncope, Hepatic-related adverse reactions, Alcohol-related hepatotoxicity, Fatigue, Anorexia, Nausea, Jaundice, Dark urine, Liver tenderness, Hepatomegaly, ALT elevation, AST elevation, Alkaline phosphatase elevation, Bilirubin elevation, Aminotransferase elevations with total bilirubin elevation > 2x ULN, Aminotransferase elevations > 8x ULN, Aminotransferase elevations > 5x ULN persisting beyond two weeks."
152,NEURACEQ,adverse reactions,"injection site reaction, erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, False positives, Errors in the estimation of brain neuritic beta-amyloid plaque density, Errors due to severe brain atrophy, Errors due to motion artifacts, Increased risk of cancer."
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, palmar-plantar erythrodysesthesia syndrome, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, hypertension, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysphagia, dyspepsia, hemorrhoids, vomiting, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, increased lipase, pancreatitis, tracheal fistula formation, vomiting, death."
155,COMETRIQ,boxed warnings,"Perforations, Fistulas, Hemorrhage, Bleeding, Hemoptysis, Gastrointestinal hemorrhage, Death"
156,COMETRIQ,warnings and precautions,"Thrombotic Events, death, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar Erythrodysesthesia syndrome, Proteinuria, Reversible posterior leukoencephalopathy syndrome, death, Gastrointestinal perforations, Fistulas, Hemorrhage, death"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, death, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, anemia, decreased potassium, thrombocytopenia, renal failure, pulmonary embolism, hypoglycemia, myocardial infarction, congestive heart failure, sudden death, acute respiratory failure, infection, acute renal failure, dehydration, abdominal pain, stomatitis, pyrexia, pneumonia, gastroenteritis, aggression, agitation, amenorrhea, hypercholesterolemia, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypophosphatemia, cellulitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"Non-infectious pneumonitis, death, infections, death, angioedema, oral ulceration, renal failure, death, impaired wound healing, death, laboratory test alterations, death, vaccinations, embryo-fetal toxicity, death"
159,BREO,adverse reactions,"LABA, vilanterol: increase the risk of asthma-related death, asthma-related death, Inhaled corticosteroids: Candida albicans infection, Inhaled corticosteroids: Increased risk of pneumonia in COPD, pneumonia, Inhaled corticosteroids: Immunosuppression, Inhaled corticosteroids: Hypercorticism and adrenal suppression, Inhaled corticosteroids: Reduction in bone mineral density, Nasopharyngitis, Upper respiratory tract infection, Headache, Oral candidiasis, oropharyngeal candidiasis, candidiasis, fungal oropharyngitis, Back pain, Bronchitis, Sinusitis, Oropharyngeal pain, Dysphonia, Cough, Influenza, Arthralgia, Pharyngitis, Pyrexia, Viral respiratory tract infection, Allergic rhinitis, Rhinitis, Supraventricular extrasystoles, Ventricular extrasystoles, Acute sinusitis, Palpitations, Tachycardia, Hypersensitivity reactions, including anaphylaxis, angioedema, rash, urticaria, Muscle spasms, Tremor, Nervousness, Death"
160,BREO,boxed warnings,"Asthma-related death, death, Increase in asthma-related deaths, Risk of asthma-related death, Increase in asthma-related hospitalization"
161,BREO,warnings and precautions,"Asthma-related death, death, Deterioration of Disease and Acute Episodes, Excessive Use of BREO ELLIPTA and Use with Other Long-Acting Beta2-Agonists, Local Effects of Inhaled Corticosteroids, Pneumonia, death, Immunosuppression, Transferring Patients from Systemic Corticosteroid Therapy, Hypercorticism and Adrenal Suppression, Drug Interactions with Strong Cytochrome P450 3A4 Inhibitors, Paradoxical Bronchospasm, death, Hypersensitivity Reactions, Including Anaphylaxis, Cardiovascular Effects, death, Reduction in Bone Mineral Density, Glaucoma and Cataracts, Coexisting Conditions, Hypokalemia and Hyperglycemia, Effect on Growth"
162,FIRAZYR,adverse reactions,"Injection site reactions, death, Pyrexia, Transaminase increase, Dizziness, Rash, Nausea, Headache"
163,FIRAZYR,warnings and precautions,"Laryngeal attacks, Airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, death, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Loss of strength or energy (asthenia), Pancreatitis, Hypersensitivity-related adverse reactions, Photosensitivity-related adverse reactions, Volume Depletion-Related Adverse Reactions, Falls, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital mycotic infections, Hypersensitivity reactions, Bone fracture, Increased LDL-C"
166,VORAXAZE,adverse reactions,"anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, death"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death, methotrexate concentrations, interference with assay, erroneous measurement, overestimates, DAMPA, leucovorin, substrate, drug interactions, hydration, alkalinization of urine."
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, death, pancreatitis, hypersensitivity reactions, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"Acute pancreatitis, Hypersensitivity, Anaphylaxis, Angioedema, Severe cutaneous adverse reactions, Hepatic failure, Death, Hypoglycemia, Arthralgia, Severe joint pain, Macrovascular risk reduction"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Headache, Migraine, Nausea, Diarrhea, Abdominal pain, Asthenia, Back pain, Pain in extremity, Alopecia, Actinic keratosis, Liver transaminase elevations (ALT/GGT/AST), Blood triglycerides increased, Cough, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, Vascular Events, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, Lymphomas, death"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, bradyarrhythmia, atrioventricular blocks, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, asystole, death, Infections, peripheral lymphocyte count reduction, serious infections, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, Progressive multifocal leukoencephalopathy (PML), probable PML, JC virus (JCV) infection, death, Macular edema, visual disturbances, blurred vision, decreased visual acuity, Posterior reversible encephalopathy syndrome (PRES), severe headache, altered mental status, visual disturbances, seizure, Decrease in forced expiratory volume over 1 second (FEV1), reduction in diffusion lung capacity for carbon monoxide (DLCO), dyspnea, Liver injury, elevation of liver enzymes, transaminase levels, bilirubin levels, hepatic dysfunction, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, Fetal risk, fetal harm, Blood pressure effects, hypertension."
172,HALAVEN,adverse reactions,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, death"
173,HALAVEN,warnings and precautions,"Neutropenia, death, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, death"
175,INTELENCE,warnings and precautions,"Severe skin reactions, Potentially life-threatening skin reactions, Fatal skin reactions, Stevens-Johnson syndrome, Hypersensitivity reaction, Toxic epidermal necrolysis, Erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), Rash with systemic symptoms, Liver transaminase elevations, Rash, Constitutional findings, Organ dysfunction, Hepatic failure, Grade 3 and 4 rashes, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), Fever, General malaise, Fatigue, Muscle or joint aches, Blisters, Oral lesions, Conjunctivitis, Facial edema, Hepatitis, Eosinophilia, Angioedema, Death."
176,AMYVID,adverse reactions,"Headache, Musculoskeletal pain, Blood pressure increased, Nausea, Fatigue, Injection site reaction, Anxiety, Back pain, Claustrophobia, Dizziness, Feeling cold, Insomnia, Neck pain, Infusion site rash, Dysgeusia, Pruritis, Urticaria, Flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, Radiation risk, Cancer, Death"
178,ULESFIA,adverse reactions,"Ocular irritation, Application site irritation, Application site anesthesia, Application site hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, Dryness, Excoriation, Paraesthesia, Dermatitis, Thermal burn, Dandruff, Rash, Skin exfoliation"
179,ULESFIA,warnings and precautions,"Neonatal toxicity, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, Eye irritation, Contact dermatitis."
180,OTEZLA,adverse reactions,"Diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, death"
181,OTEZLA,warnings and precautions,"Depression, Suicidal thoughts, Mood changes, Weight decrease, Weight loss, Drug interactions, Death"
182,ILARIS,adverse reactions,"nasopharyngitis, diarrhea, influenza, headache, nausea, infections, upper respiratory tract infections, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, rhinitis, bronchitis, weight increased, vertigo, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, hypersensitivity, anaphylactic reactions, antibodies, laboratory findings, white blood cells, neutrophils, platelets, transaminases, ALT, AST, bilirubin, death"
183,ILARIS,warnings and precautions,"Serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus infections, herpes zoster infections, tuberculosis, opportunistic infections, immunosuppression, risk of malignancies, hypersensitivity reactions, macrophage activation syndrome"
184,NATAZIA,adverse reactions,"Serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraines, pain, menstrual disorders, vomiting, acne, mood changes, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, abdominal pain, vulvovaginal candidiasis, death"
185,NATAZIA,boxed warnings,"Serious cardiovascular events, Cardiovascular events, death"
186,NATAZIA,warnings and precautions,"Thrombotic event, thromboembolic event, venous thromboembolism, VTE, arterial thromboses, strokes, myocardial infarctions, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, loss of vision, proptosis, diplopia, papilledema, liver disease, jaundice, hepatic adenomas, hepatocellular carcinoma, gallbladder disease, carbohydrate metabolic effects, lipid metabolic effects, glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, migraine, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, intracyclic bleeding, depression, interference with laboratory tests, drug interactions, hereditary angioedema, chloasma."
187,DIFICID,adverse reactions,"Nausea, Vomiting, Abdominal pain, Gastrointestinal hemorrhage, Anemia, Neutropenia, Death"
188,DIFICID,warnings and precautions,"Acute hypersensitivity reactions, Angioedema, Dyspnea, Pruritus, Rash, Angioedema of the mouth, throat, and face, Allergy to other macrolides, Development of drug-resistant bacteria"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior, Ideation, Constipation, Pyrexia, Lethargy, Drooling, Death (if fatal event is listed), Ataxia, Aggression, Fatigue, Insomnia, Irritability, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Psychomotor hyperactivity, Dysarthria, Cough, Anemia, Eosinophilia, Leukopenia, Thrombocytopenia, Diplopia, Blurred vision, Abdominal distention, Hypothermia, Increased hepatic enzymes, Muscle spasms, Agitation, Anxiety, Apathy, Confusional state, Depression, Delirium, Delusion, Hallucination, Urinary retention, Aspiration, Respiratory depression, Rash, Urticaria, Angioedema, Facial and lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, Central nervous system (CNS) depression, Withdrawal symptoms, Serious dermatological reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical dependence, Psychological dependence, Substance abuse, Suicidal behavior, Suicidal ideation, death"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Gastrointestinal events, Hepatic Transaminases, Eosinophilia"
192,TECFIDERA,warnings and precautions,"Anaphylaxis, angioedema, death, Progressive Multifocal Leukoencephalopathy, PML, lymphopenia, Flushing"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, feeling abnormal, muscle atrophy, dyspnea, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, blood present in urine, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, depression, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness, antibody formation, binding antibodies, neutralizing antibodies."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"Dysphagia, swallowing difficulties, breathing difficulties, respiratory disorders, respiratory failure, aspiration, severe dysphagia, severe breathing difficulties, respiratory compromise, severe dysphagia, respiratory disorders, respiratory failure, death, Speech difficulties, dysphonia, Asthenia, generalized muscle weakness, Diplopia, blurred vision, Ptosis, Dysarthria, Urinary incontinence, Life-threatening symptoms, Facial asymmetry, Eyelid ptosis"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, myopathy, rhabdomyolysis, non-infectious pneumonitis, insomnia, falls, hematuria, rash, pyrexia, groin pain, constipation, dyspnea, cardiac arrest, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, sudden death, death."
197,ZYTIGA,warnings and precautions,"Hypertension, high blood pressure, Hypokalemia, low potassium levels, Fluid retention, edema, Adrenocortical insufficiency, adrenal insufficiency, Hepatotoxicity, liver toxicity"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, Muscle spasms, Nausea, Diarrhea, Dyspepsia, Abdominal pain upper, Oropharyngeal pain, Dizziness, Neck pain, Venous thromboembolism, Death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis, dementia, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, death"
200,DUAVEE,warnings and precautions,"Cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, stroke, coronary heart disease, dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, hypertriglyceridemia, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, premenopausal use, drug-laboratory test interactions, accelerated prothrombin time, partial thromboplastin time, platelet aggregation time, increased platelet count, increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex, beta-thromboglobulin, decreased levels of antifactor Xa, antithrombin III, decreased antithrombin III activity, increased levels of fibrinogen, fibrinogen activity, increased plasminogen antigen, plasminogen activity, increased thyroid-binding globulin, increased circulating total thyroid hormone, protein-bound iodine, T4 levels, T3 levels, T3 resin uptake, free T4, free T3 concentrations, elevated TBG, other binding proteins, corticosteroid binding globulin, sex hormone-binding globulin, free hormone concentrations, testosterone, estradiol, plasma proteins, angiotensinogen/renin substrate, alpha-1-antitrypsin, ceruloplasmin, increased plasma high-density lipoprotein, HDL cholesterol subfraction concentrations, reduced low-density lipoprotein cholesterol concentrations, increased triglyceride levels, impaired glucose tolerance."
201,SAPHRIS,adverse reactions,"Neuroleptic Malignant Syndrome, NMS, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions including oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Akathisia, Oral Hypoesthesia, Somnolence, Dizziness, Extrapyramidal symptoms, Increased weight, Dysgeusia, Oral Paresthesia, Nausea, Increased appetite, Fatigue, Anxiety, Depression, Insomnia, Irritability, Arthralgia, Pain in extremity, Headache, Hypertension, Dysmenorrhea, Oral paraesthesia, Toothache, Dry mouth, Glossodynia, Edema peripheral, Myalgia, Bradykinesia, Oromandibular dystonia, Muscle contractions involuntary, Muscle twitching, Musculoskeletal stiffness, Parkinsonism, Protrusion tongue, Resting tremor, Tremor, Suicidal ideation, Anger, Dehydration, Rash, Tachycardia, Heart rate increased, Vomiting, Abdominal pain, Abdominal pain upper, Abdominal pain lower, Abdominal discomfort, Muscle strain, Hyperinsulinemia, Blood insulin increased, ALT increased, AST increased, Oropharyngeal pain, Nasal congestion, Dyspnea, Dyspepsia, Oral hypoesthesia, Increased appetite, Death"
202,SAPHRIS,boxed warnings,"Increased mortality, Death"
203,SAPHRIS,warnings and precautions,"Cerebrovascular Adverse Events, Stroke, Transient Ischemic Attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Anaphylaxis, Angioedema, Orthostatic Hypotension, Syncope, Dizziness, Tachycardia, Bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Potential for Cognitive and Motor Impairment, Suicide, Death, Dysphagia, Aspiration pneumonia."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, conjunctival hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, Cataracts, posterior subcapsular cataract formation, Delayed healing, bleb formation, perforations in thinning cornea or sclera, Bacterial infections, suppression of host response, secondary ocular infections, Viral infections, exacerbation of severity, prolonged course, Fungal infections, corneal ulceration, fungus invasion, Death"
206,ZYDELIG,adverse reactions,"Hepatotoxicity, liver damage, Severe Diarrhea, severe colitis, Pneumonitis, lung inflammation, Intestinal Perforation, bowel perforation, Severe Cutaneous Reactions, severe skin reactions, Anaphylaxis, severe allergic reaction, Neutropenia, low white blood cell count, Diarrhea, colitis, Pyrexia, fever, Fatigue, Nausea, Cough, Pneumonia, Abdominal pain, Chills, Rash, Death"
207,ZYDELIG,boxed warnings,"Hepatic toxicity, Severe diarrhea, Colitis, Pneumonitis, Intestinal perforation, Death"
208,ZYDELIG,warnings and precautions,"Severe cutaneous reactions, toxic epidermal necrolysis, dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, anaphylaxis, neutropenia, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death."
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, upper respiratory tract infection, death"
210,KALBITOR,boxed warnings,"Anaphylaxis, Hypersensitivity reactions"
211,KALBITOR,warnings and precautions,"Anaphylaxis, death, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, pruritus, rash."
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Death"
213,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection, Death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathy, sensory neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, liver injury, transaminases elevation, bilirubin elevation, progressive multifocal leukoencephalopathy, JC virus infection, PML, pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations, death"
215,BESIVANCE,adverse reactions,"Conjunctival redness, eye redness, Blurred vision, Eye pain, Eye irritation, Eye pruritus, itchy eyes, Headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms, Overgrowth of non-susceptible organisms, Fungal overgrowth, Super-infection, Signs or symptoms of bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, death, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation."
218,CLEVIPREX,warnings and precautions,"Hypotension, Reflex tachycardia, Negative inotropic effects, Exacerbate heart failure, Rebound hypertension, Death"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls, fall-related injuries, hypertension, death."
220,XTANDI,warnings and precautions,"Seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT elevation, SGOT/AST elevation, Lipase elevation, Phosphorus (Low), Total Bilirubin elevation, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Anaphylactic shock, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption, Death."
222,BOSULIF,warnings and precautions,"Diarrhea, nausea, vomiting, abdominal pain, Thrombocytopenia, anemia, neutropenia, ALT elevation, AST elevation, transaminase elevations, Pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, Decline in estimated glomerular filtration rate (eGFR), Fetal harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, Injury to the brain, Death"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, death, Upper respiratory tract infection, Viral infection, Bronchitis, Hypertension, Rash, Infections, Sepsis, Pneumonia, Cellulitis, Abscess, Opportunistic infections, Tuberculosis, Invasive fungal infections, Malignancies, Liver Enzyme Elevations, Autoimmune Disorders, Autoantibodies, Administration Reactions, Immunogenicity, Infusion reaction, Antibodies, Neoplasm Benign and Malignant, Immune System Disorders, Respiratory disorders, Skin disorders, Superficial fungal infection, Sinusitis, Lower respiratory tract infection, Pyelonephritis, Alanine aminotransferase increased, Aspartate aminotransferase increased, Neutrophil count decreased, Dizziness, Paresthesia, Constipation, Melanoma, Serious systemic hypersensitivity reactions, Sarcoidosis, Interstitial lung disease, Skin exfoliation, Bullous skin reactions"
226,SIMPONI,boxed warnings,"Serious infections, Hospitalization, Death, Tuberculosis, Bacterial sepsis, Invasive fungal infections, Histoplasmosis, Other opportunistic infections, Lymphoma, Malignancies"
227,SIMPONI,warnings and precautions,"Serious infections, death, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, exacerbation, new onset, hypersensitivity reactions, anaphylaxis"
228,BENLYSTA,adverse reactions,"Mortality, death, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, viral gastroenteritis, fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"Mortality, death, Serious Infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), fatal cases, Hypersensitivity Reactions, Anaphylaxis, fatal reactions, Depression, suicidality, serious depression, suicides, Infusion Reactions, serious infusion reactions, Malignancy, Immunization"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, death, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema, face angioedema, lips angioedema, tongue angioedema, larynx angioedema, bladder outlet obstruction, urinary retention, decreased gastrointestinal motility, severe constipation, narrow-angle glaucoma, central nervous system effects, somnolence, myasthenia gravis"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"Myocardial infarction, Heart attack, Death"
234,ENTEREG,warnings and precautions,"Myocardial infarctions, death, abdominal pain, nausea, vomiting, diarrhea, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, surgery for correction of complete bowel obstruction, pancreatic anastomosis, gastric anastomosis"
235,VIZAMYL,adverse reactions,"flushing, increased blood pressure, headache, nausea, dizziness"
236,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, Image interpretation errors, false positives, Radiation risk"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, Urinary tract infection, Insomnia, Dizziness, Headache, Nausea, Asthenia, Back pain, Balance disorder, Multiple sclerosis relapse, Paresthesia, Nasopharyngitis, Constipation, Dyspepsia, Pharyngolaryngeal pain, Death"
238,AMPYRA,warnings and precautions,"Seizures, death, anaphylaxis"
